The anti‑HER3 IgG1 binds HER3 on target cells and its Fc engages Fcγ receptors on effector cells (e.g., NK cells) to trigger ADCC, leading to lysis of HER3-positive cells; signaling blockade is antiproliferative but not the primary killing mechanism.